14 years of healthcare traffic,
compounding in public.
Owner-verified Google Analytics from an editorial portfolio Chris Riley built and operated personally. Every chart is from the period he operated the property. Every byline is named.
Traffic is the first receipt, not the asset.
Under every graph is a moat the chart can't show: clinicians who wrote under the byline, journalists who cited the property, partners who closed because of the paper trail, and, in several cases, acquirers who paid for the asset. USARx.com is the 11-year flagship Chris led at a prescription-savings company from 2012 to 2023. Diabetic.org, Pharmacists.org, and Allergies.org were a separate owned portfolio Chris built and exited in 2023. Circufiber.com was a 2+ year Experts Ink client engagement (DTC diabetic-sock brand, since shuttered). Beyond what is shown, Experts Ink runs 28+ current client engagements across treatment centers, behavioral health, specialty pharmacy, DTC brands, telehealth, and consumer health publishing. Most are under NDA and aggregated at the bottom of this page.
- 01
Health Clinics
Multi-location medical practices, specialty groups, dental & concierge.
- 02
Digital Health Brands
DTC supplement, OTC, device, wearable & app brands.
- 03
Digital Health Media
Consumer health publishers, comparison sites & review media.
- 04
Treatment Centers
Addiction, behavioral health, IOP/PHP & residential programs.
- USARx.com
- Diabetic.org
- Pharmacists.org
- Allergies.org
0 → 1.5M organic sessions / mo.
14,000 peer-reviewed articles over 11 years. The site that became the playbook for Experts Ink.
Chris Riley ran SEO and editorial at USARx.com from 2012 through 2023. Across 11 years his team shipped 14,000 peer-reviewed articles, drug monographs, and condition pages, growing the property from zero to a 1.5M organic sessions / mo peak in 2023. USARx is where Chris became a medical writer himself, where he first worked with Alex (then doing content at GoodRx), and where the in-the-trenches version of the Experts Ink playbook was built. Chris departed USARx in 2023 and stood up Experts Ink around everything the 11-year run had proven.
- Flagship · 2012-2023
- 14,000 articles
- 1.5M sessions peak
- Organic sessions / mo
- 1.5M (2023 peak)
- Articles published (peer-reviewed)
- 14,000+
- Ranked keywords (top-10)
- 48,000+
- Google core-update survival (tenure)
- 7 / 7
“USARx is where I learned what healthcare content actually is. Eleven years, 14,000 articles, one standard of evidence: real clinicians, named, on every piece. That's the playbook I took into Experts Ink.”
$0 → six-figure monthly organic revenue.
A DTC diabetic-sock brand Experts Ink built the podiatrist-reviewed content layer for over 2+ years.
Circufiber was a direct-to-consumer copper-fiber compression sock brand targeting diabetic foot, neuropathy, and circulation patients. Experts Ink ran content for the brand for 2+ years: podiatrist-reviewed explainers on diabetic foot ulcers, venous insufficiency, and plantar neuropathy, plus PDP copy and a medical-claim audit. That clinical foundation gave the brand a PDP trust curve DTC competitors in the compression category never matched. The brand has since shuttered; the editorial archive and organic performance during the engagement window are what this case study is.
- Client engagement · DTC
- Podiatrist-reviewed
- 2+ year retainer
- Organic sessions / mo (peak)
- 148k
- Podiatrist-reviewed articles
- 260+
- Organic revenue / mo (peak)
- Six figures
- Engagement length
- 2+ years
“Compression socks is the most commoditized corner of DTC. The category gets won with one thing competitors don't have: a real podiatrist on every explainer. The trust curve is the asset, not the traffic.”
8k → ~720k peak sessions / mo.
A CDCES-reviewed diabetes publisher that went head-to-head with Healthline on hundreds of high-intent queries.
Diabetic.org is a consumer health property Chris built and ran personally, covering type-1, type-2, GLP-1s, insulin regimens, CGMs, and diabetic complications. Every clinical page was reviewed by a Certified Diabetes Care and Education Specialist (CDCES) or a board-certified endocrinologist. Three years of patient, peer-reviewed publishing built a content moat that ranked #1 against WebMD and Healthline on dozens of diabetes topics patients actually search. Part of a portfolio Chris exited in 2023.
- Owned property
- CDCES-reviewed
- Acquired 2023
- Organic sessions / mo (peak)
- ~720k
- CDCES / endocrinologist-reviewed articles
- 2,400+
- Ranked #1 vs Healthline / WebMD
- Dozens of terms
- Years operated
- ~3
“Same playbook USARx ran, narrower niche. Real CDCES bylines, real peer review, years of patience. Volume shortcuts didn't beat it. Nobody's shortcut did.”
0 → ~520k peak sessions / mo.
Built into the highest-ranking independent PharmD authority site on the open web, then acquired.
Pharmacists.org is a publisher Chris built from zero covering PharmD career paths, state licensure, clinical specialization, and pharmacist-authored consumer drug content. Every clinical piece was written or reviewed by a board-certified PharmD with a linked-out professional profile and conflict-of-interest disclosure. By exit in 2023 it was the highest-ranking independent pharmacist authority site on the open web. Part of the portfolio Chris sold that year.
- Owned property
- PharmD-reviewed
- Acquired 2023
- Organic sessions / mo (peak)
- ~520k
- PharmD-reviewed articles
- 1,800+
- Top-3 rankings (PharmD career queries)
- 400+
- Years operated
- ~3
“If you want to rank for what a pharmacist searches for, you need a pharmacist on the byline. That was the whole rule. That's the rule that got acquired.”
28+ client engagements since the portfolio exit. Names redacted, receipts aggregated.
Everything above was the build. This is the current business. Since 2023, Experts Ink has run the same playbook for treatment centers, behavioral health programs, multi-location clinics, specialty pharmacies, DTC brands, telehealth companies, and consumer-health publishers across the US. Most don't want their editorial strategy on a competitor's desk. Fair. Names available on a private call under mutual NDA.
Give us a brief.
We'll send back a plan.
Tell us the brand, the reader, and the goal. Within three business days a credentialed clinician on our desk will hand-write a free editorial teardown and a 90-day roadmap. Yours to keep, even if you never hire us.
- · Written by a real MD / PharmD / RD, not a sales rep
- · 3 business days
- · No meeting required